Changes in parameter over the follow-up period
Muscle mass (kg)-, end-stage liver disease
Table 
Changes in clinical and laboratory parameters from baseline to week 8 and 16 within each groupBalancing test(second)- Muscle mass (kg)- SMI (kg/m- Fat free mass (kg)19.3 ± 5.47.5 ± 1.645.2 ± 9.919.6 ± 5.37.7 ± 1.644.9 ± 9.80.260.260.5219.9.2 ± 5.47.8 ± 1.545.1 ± 10.40.060.030.7620.1 ± 3.87.8 ± 1.246.5 ± 7.120.2 ± 3.47.8 ± 1.146.9 ± 6.50.920.900.4420.2.2 ± 3.67.8 ± 1.146.6 ± 6.70.950.970.96*P-value for comparison between baseline vs. week 8**P-value for comparison between baseline vs. week 16BMI, body mass index; MELD, model for end-stage liver disease; LFI, liver frailty index; HGS, hand grip strength; CST, chair stands test; SKI, skeletal muscle index